A Phase 1 Study of Budoprutug (TNT119) Subcutaneous and Intravenous Injections in Normal Healthy Volunteers

Clinical trial NCT07090655 · COMPLETED

Trial details

NCT number: NCT07090655
Sponsor: Climb Bio, Inc.
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Healthy Volunteers

Start date: 2025-08-11
Primary completion: 2026-04-07
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.